Genomically informed small-molecule drugs overcome resistance to a sustained-release formulation of an engineered death receptor agonist in patient-derived tumor models. - Manzari MT; Anderson GR; Lin KH; Soderquist RS; Çakir M; Zhang M; Moore CE; Skelton RN; Fèvre M; Li X; Bellucci JJ; Wardell SE; et al. (Science advances, 2019)